The relevance of apoptosis for cellular homeostasis and tumorigenesis in the intestine

Canadian Journal of Gastroenterology

Volumn 15, Issue 3, 2001, Pages 166-176

  Renehan, A G ^a   Bach, S P ^a   Potten, C S ^a  

^a Epistem Ltd   (United Kingdom)

Author keywords

Apoptosis; Bcl 2 family; Gastrointestinal cancer; Intestinal crypt; p53; Stem cell

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; BETULIC ACID; CASPASE; CYCLOOXYGENASE 2 INHIBITOR; CYTOTOXIC AGENT; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PROTEIN BCL 2; PROTEIN C JUN; PROTEIN P53; PYRROLIDINEDITHIOCARBAMATE; RETINOID DERIVATIVE; SULINDAC; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CARCINOGENESIS; CELL CYCLE S PHASE; CELL DEATH; CELL PROLIFERATION; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; GENETIC REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; INTESTINE CANCER; INTESTINE CRYPT; INTESTINE EPITHELIUM; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0034802249     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/164727     Document Type: Review

References (132)

1. Cell death: The significance of apoptosis
2. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
3. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview
4. Apoptosis in the pathogenesis and treatment of disease
5. Advances in apoptosis research
6. Normal development, oncogenesis and programmed cell death
7. A matter of life and cell death
8. Mitochondria and apoptosis
9. Drug-target interactions: Only the first step in the commitment to a programmed cell death?
10. Apoptosis and cancer chemotherapy
11. Apoptosis and gastrointestinal pharmacology
12. Cell death in vertebrate ontogeny
13. Programmed cell death: Cytology of degeneration in the intersegmental muscles of the silkmoth
14. Apoptosis: Mechanisms and roles in pathology
15. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
16. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states
17. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers
18. What is an apoptotic index measuring? A commentary
19. Assessing apoptosis: A critical survey
20. Assessment of cell proliferation in pathology - What next?
21. Signal transduction pathways that regulate cell survival and cell death
22. Stress signals for apoptosis: Ceramide and c-Jun kinase
23. Human ICE/CED-3 protease nomenclature
24. Caspases: The proteases of the apoptotic pathway
25. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition
26. Insights from Bcl-2 and Myc: Malignancy involves abrogation of apoptosis as well as sustained proliferation
27. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
28. Death signalling in C. elegans and activation mechanisms of caspases
29. Genetic control of programmed cell death in the nematode Caenorhabditis elegans
30. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans
31. The ins and outs of programmed cell death during C. elegans development
32. Molecular cloning of the interleukin-1 beta converting enzyme
33. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes
34. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
35. Involvement of the bcl-2 gene in human follicular lymphoma
36. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
37. Bcl-2 and the regulation of programmed cell death
38. BCL-2 gene family and the regulation of programmed cell death
39. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
40. The biochemistry of programmed cell death
41. Bcl-2-family proteins: The role of the BH3 domain in apoptosis
42. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
43. Immunohistochemical analysis of in vivo patterns of Bcl-X expression
44. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
45. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
46. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K
47. T antigen is bound to a host protein in SV40-transformed cells
48. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
49. p53 mutations in human cancers
50. Cancer progression and p53
51. The p53 tumour suppressor gene
52. The role of p53 in apoptosis
53. Cancer. p53, guardian of the genome
54. p53-dependent apoptosis suppresses radiation-induced teratogenesis
55. The high susceptibility of heterozygous p53(+/-) mice to malformation after foetal irradiation is related to sub-competent apoptosis
56. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
57. A model for p53-induced apoptosis
58. Radiation-induced p53 and p21WAF-1/CIP1 expression in the murine intestinal epithelium: Apoptosis and cell cycle arrest
59. The emerging p53 gene family
60. Control of apoptosis through gene regulation
61. Structure, function and proliferative organisation of mammalian gut
62. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice
63. The intestinal epithelial stem cell: The mucosal governor
64. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium
65. Stem cells in gastrointestinal epithelium: Numbers, characteristics and death
66. The number of clonogenic cells in crypts in three regions of murine large intestine
67. Further studies on the response of intestinal crypt cells of different hierarchical status to eighteen different cytotoxic agents
68. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice
69. Increased intestinal Bak expression results in apoptosis
70. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis
71. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis
72. Analysis of the cell death in the mucoid epithelium of mouse stomach
73. Helicobacter pylori infection and the risk of gastric carcinoma
74. Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis
75. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis
76. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia
77. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2
78. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo
79. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family
80. Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines
81. Immunohistochemical localization of BAX and BAD in normal and BCL-2 null gastrointestinal tract
82. Apoptosis in small intestinal epithelial from p53-null mice: Evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation
83. Regulation and significance of apoptosis in stem cells of the gastrointestinal epithelium
84. Apoptosis and cancer mechanisms
85. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)
86. p53-dependent apoptosis suppresses tumor growth and progression in vivo
87. Induction versus progression of brain tumor development: Differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen
88. p53-dependent apoptosis in vivo: Impact of p53 inactivation on tumorigenesis
89. Inhibition of apoptosis during development of colorectal cancer
90. Increased apoptosis accompanies neoplastic development in the human colorectum
91. Aspirin, NSAIDS, and colon cancer prevention: Mechanisms?
92. Fas counter-attack-the best form of tumor defense?
93. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
94. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
95. Problems with p53 immunohistochemical staining: The effect of fixation and variation in the methods of evaluation
96. Suppression of human colorectal carcinoma cell growth by wild-type p53
97. p53 expression in colorectal tumors
98. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma
99. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
100. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy
101. BCL-2 expression in human colorectal adenomas and carcinomas
102. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis
103. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model
104. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas
105. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma
106. The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
107. bcl-2 protein in non-small-cell lung carcinoma
108. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
109. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas
110. Bcl-w expression in colorectal adenocarcinoma
111. Therapeutic manipulation of apoptosis in cancer and neurological disease
112. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia
113. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
114. p53 abnormalities in C11 are associated with excess of prolymphocytes and poor prognosis
115. Lipid metabolism and APC: Implications for colorectal cancer prevention
116. Importance of apoptosis in the histopathology of drug related lesions in the large intestine
117. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
118. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
119. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299
120. WAF1/CIP1 via C/EBPbeta
121. Biochemistry of cell death
122. Features of apoptotic cells measured by flow cytometry
123. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry
124. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
125. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
126. Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system
127. Demonstration of apoptotic cells in tissue sections by in situ hybridization using digoxigenin-labeled poly(A) oligonucleotide probes to detect thymidine-rich DNA sequences
128. bcl-w, a novel member of the bcl-2 family, promotes cell survival
129. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
130. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
131. The proto-oncogene c-myc and apoptosis
132. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity